| Product Name | Anti-CD30 (brentuximab vedotin biosimilar) mAb |
|---|---|
| CAS | 914088-09-8 |
| Storage condition | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥7500.00 | Visible after login | |
| 5 mg | 3-5days | ¥35600.00 | Visible after login | |
| 10 mg | 3-5days | ¥64000.00 | Visible after login |
| Product Name | Anti-CD30 (brentuximab vedotin biosimilar) mAb |
|---|---|
| CAS | 914088-09-8 |
| Storage condition | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
Brentuximab vedotin (SGN-35; Adcetris,cAC10-vcMMAE) is an anti-CD30 antibody conjugated via a protease-cleavable linker to the potent anti-microtubule agent monomethyl auristatin E (MMAE). Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma.